Veracyte, Inc.
VCYT$4.28B
Mid CapNASDAQServices-Medical Laboratories🇺🇸North AmericaSOUTH SAN FRANCISCO824 employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jul 30, 2026
16dMarket Overview
Stock performance and key metrics
VCYT News
Catalyst Timeline
1 upcoming, 0 past
How VCYT's past catalysts played out
Drug Pipeline
No drugs found in this phase.
📑
→Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
Catalyst Verdict
Full breakdown — the signals behind the verdict
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is Veracyte, Inc.'s next FDA catalyst?→
Veracyte, Inc.'s (VCYT) next tracked catalyst is a Earnings expected July 30, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track VCYT biotech catalysts?→
Add VCYT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Veracyte, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply